Biosafety Testing. Diaclone shall conduct and pay for the Biosafety Testing in accordance with Exhibit F attached hereto (provided that Xcyte shall pre-approve any costs that materially differ from the estimated costs set forth in Exhibit F attached hereto) and invoice Xcyte for reimbursement. Xcyte shall pay all undisputed amounts on such invoice within forty-five (45) days of receipt thereof.
Appears in 3 contracts
Sources: License and Supply Agreement (Xcyte Therapies Inc), License and Supply Agreement (Xcyte Therapies Inc), License and Supply Agreement (Xcyte Therapies Inc)